What are the major opportunities in the Genomic Biomarkers market? What are the strategies for the Genomic Biomarkers market?

For detailed insights on the major opportunities and strategies in the Genomic Biomarkers market, Read More

How does the Genomic Biomarkers market relate to the overall economy and other similar markets?

For detailed insights on Genomic Biomarkers's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Genomic Biomarkers market growth? SWOT analysis of the Genomic Biomarkers market.

For detailed insights on the key dynamics influencing the Genomic Biomarkers market growth and SWOT analysis of the Genomic Biomarkers industry, Read More

Genomic Biomarkers Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Genomic Biomarkers Market Report 2026

Name: Genomic Biomarkers Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Predictive Biomarkers, Prognostic Biomarkers), By Disease Indication (Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications), By Validation (Analytical Validation, Clinical Validation, Clinical Utility), By End-User (Hospitals, Diagnostic Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Genomic Biomarkers Market Overview

• Genomic Biomarkers market size has reached to $8.72 billion in 2025

• Expected to grow to $19.33 billion in 2030 at a compound annual growth rate (CAGR) of 17.2%

• Growth Driver: Growth Of Genomic Biomarkers Market Driven By Personalized Medicine Demand

• Market Trend: Advancements In Genomic Biomarkers To Enhance Precision Medicine In Lung Cancer

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Genomic Biomarkers Market?

Genomic biomarkers are specific sequences or variations in DNA or RNA that provide information about a biological process, condition, or response to a particular treatment. These biomarkers are used in precision medicine to predict disease risk, diagnose conditions, monitor disease progression, or guide treatment decisions. Genomic biomarkers are crucial for personalized medicine, allowing healthcare providers to tailor treatments based on an individual's genetic makeup, improving the effectiveness of therapies, and reducing the likelihood of adverse effects.

The main types of genomic biomarkers are predictive biomarkers and prognostic biomarkers. Predictive biomarkers are biological molecules found in blood, other body fluids, or tissues that indicate whether a patient is likely to benefit from a particular medical treatment or intervention. The various disease indications include oncology, cardiovascular diseases, neurological diseases, renal disorders, and others with various validation such as analytical validation, clinical validation, and clinical utility. These are used by various end-users such as hospitals, diagnostic centers, and others.

Genomic Biomarkers Market Global Report 2026 Market Report bar graph

What Is The Genomic Biomarkers Market Size and Share 2026?

The genomic biomarkers market size has grown rapidly in recent years. It will grow from $8.72 billion in 2025 to $10.24 billion in 2026 at a compound annual growth rate (CAGR) of 17.5%. The growth in the historic period can be attributed to advancements in genomic sequencing technologies, expansion of oncology-focused biomarker research, increasing adoption of personalized treatment approaches, improvements in clinical validation frameworks, rising availability of genomic databases.

What Is The Genomic Biomarkers Market Growth Forecast?

The genomic biomarkers market size is expected to see rapid growth in the next few years. It will grow to $19.33 billion in 2030 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to increasing investments in precision medicine programs, rising demand for early disease detection tools, expansion of biomarker-driven drug development, growing integration of ai in biomarker analysis, increasing regulatory support for personalized therapies. Major trends in the forecast period include increasing adoption of biomarker-guided precision medicine, rising integration of genomic data in clinical decision-making, growing use of companion diagnostics, expansion of multi-omics biomarker platforms, enhanced focus on clinical validation standards.

Book your 30 minutes free consultation with our research experts

Global Genomic Biomarkers Market Segmentation

1) By Type: Predictive Biomarkers, Prognostic Biomarkers

2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications

3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility

4) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By Predictive Biomarkers: Drug Response Biomarkers, Companion Diagnostics Biomarkers, Pharmacodynamic Biomarkers, Predictive Genetic Markers for Disease Susceptibility

2) By Prognostic Biomarkers: Cancer Prognostic Biomarkers, Cardiovascular Disease Prognostic Biomarkers, Neurodegenerative Disease Prognostic Biomarkers, Infectious Disease Prognostic Biomarkers

What Is The Driver Of The Genomic Biomarkers Market?

The increasing demand for personalized medicine is expected to propel the growth of the genomic biomarkers market going forward. Personalized medicine, also known as precision medicine, is a medical approach that tailors healthcare decisions and treatments to the individual characteristics of each patient, primarily based on their genetic and genomic information. The increasing demand for personalized medicine is due to several factors, such as the growing emphasis on patient-centered care, genetic sequencing and analysis advances, a patient-centric approach, and the use of EHRs to store and analyze patient data. Genomic biomarkers play a crucial role in personalized medicine by enabling healthcare providers to tailor medical treatments to an individual’s unique genetic makeup. This approach, also known as precision medicine, aims to optimize the effectiveness of treatments and minimize side effects by considering the genetic differences between individuals. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing demand for personalized medicine drives the growth of the genomic biomarkers industry.

Key Players In The Global Genomic Biomarkers Market

Major companies operating in the genomic biomarkers market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4

Global Genomic Biomarkers Market Trends and Insights

Major companies operating in the genomic biomarkers market are focused on developing innovative products, such as lung reagents, to enhance the detection of specific genetic mutations in lung cancer, improve diagnostic accuracy, and facilitate personalized treatment approaches by leveraging advanced genomic technologies. Lung reagents refer to specialized chemical or biological substances used in diagnostic tests, research, or medical procedures related to the lungs helping in precision medicine by guiding treatment choices based on the specific genetic profile of the cancer. For instance, in December 2023, Biofidelity, a UK-based company specializing in developing advanced genomic assays and precision diagnostics, launched ASPYRE-Lung reagents. The ASPYRE-Lung reagents are designed to identify key genetic mutations and alterations in lung cancer, which are critical for guiding targeted therapies and personalized treatment strategies.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Genomic Biomarkers Market?

In October 2025, Guardant Health, Inc., a US-based precision oncology company, entered into a strategic partnership with Zephyr AI, Inc., a US-based precision medicine company specializing in artificial intelligence. Through this collaboration, the companies aim to accelerate the development of novel cancer biomarkers by integrating Guardant Health’s multimodal molecular and real-world oncology data with Zephyr AI’s advanced AI/ML analytics platform. Zephyr AI, Inc. applies artificial intelligence and machine learning technologies to support biomarker discovery, drug development, and personalized treatment strategies.

Regional Outlook

North America was the largest region in the genomic biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genomic Biomarkers Market?

The genomic biomarkers market consists of sales of genomic biomarker panels, real-time PCR detection systems, and droplet digital PCR (ddPCR) systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genomic Biomarkers Market Report 2026?

The genomic biomarkers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genomic biomarkers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Genomic Biomarkers Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$10.24 billion
Revenue Forecast In 2035	$19.33 billion
Growth Rate	CAGR of 17.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Disease Indication, Validation, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Genomic Biomarkers Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Genomic Biomarkers Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Genomic Biomarkers Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Genomic Biomarkers Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Biomarker-Guided Precision Medicine

4.2.2 Rising Integration Of Genomic Data In Clinical Decision-Making

4.2.3 Growing Use Of Companion Diagnostics

4.2.4 Expansion Of Multi-Omics Biomarker Platforms

4.2.5 Enhanced Focus On Clinical Validation Standards

5. Genomic Biomarkers Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centers

5.3 Pharmaceutical Companies

5.4 Biotechnology Firms

5.5 Research Laboratories

6. Genomic Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Genomic Biomarkers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Genomic Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Genomic Biomarkers Market Size, Comparisons And Growth Rate Analysis

7.3. Global Genomic Biomarkers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Genomic Biomarkers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Genomic Biomarkers Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Genomic Biomarkers Market Segmentation

9.1. Global Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Predictive Biomarkers, Prognostic Biomarkers

9.2. Global Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications

9.3. Global Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Analytical Validation, Clinical Validation, Clinical Utility

9.4. Global Genomic Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Centers, Other End-Users

9.5. Global Genomic Biomarkers Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Response Biomarkers, Companion Diagnostics Biomarkers, Pharmacodynamic Biomarkers, Predictive Genetic Markers for Disease Susceptibility

9.6. Global Genomic Biomarkers Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cancer Prognostic Biomarkers, Cardiovascular Disease Prognostic Biomarkers, Neurodegenerative Disease Prognostic Biomarkers, Infectious Disease Prognostic Biomarkers

10. Genomic Biomarkers Market Regional And Country Analysis

10.1. Global Genomic Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Genomic Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Genomic Biomarkers Market

11.1. Asia-Pacific Genomic Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Genomic Biomarkers Market

12.1. China Genomic Biomarkers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Genomic Biomarkers Market

13.1. India Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Genomic Biomarkers Market

14.1. Japan Genomic Biomarkers Market Overview

14.2. Japan Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Genomic Biomarkers Market

15.1. Australia Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Genomic Biomarkers Market

16.1. Indonesia Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Genomic Biomarkers Market

17.1. South Korea Genomic Biomarkers Market Overview

17.2. South Korea Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Genomic Biomarkers Market

18.1. Taiwan Genomic Biomarkers Market Overview

18.2. Taiwan Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Genomic Biomarkers Market

19.1. South East Asia Genomic Biomarkers Market Overview

19.2. South East Asia Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Genomic Biomarkers Market

20.1. Western Europe Genomic Biomarkers Market Overview

20.2. Western Europe Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Genomic Biomarkers Market

21.1. UK Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Genomic Biomarkers Market

22.1. Germany Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Genomic Biomarkers Market

23.1. France Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Genomic Biomarkers Market

24.1. Italy Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Genomic Biomarkers Market

25.1. Spain Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Genomic Biomarkers Market

26.1. Eastern Europe Genomic Biomarkers Market Overview

26.2. Eastern Europe Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Genomic Biomarkers Market

27.1. Russia Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Genomic Biomarkers Market

28.1. North America Genomic Biomarkers Market Overview

28.2. North America Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Genomic Biomarkers Market

29.1. USA Genomic Biomarkers Market Overview

29.2. USA Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Genomic Biomarkers Market

30.1. Canada Genomic Biomarkers Market Overview

30.2. Canada Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Genomic Biomarkers Market

31.1. South America Genomic Biomarkers Market Overview

31.2. South America Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Genomic Biomarkers Market

32.1. Brazil Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Genomic Biomarkers Market

33.1. Middle East Genomic Biomarkers Market Overview

33.2. Middle East Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Genomic Biomarkers Market

34.1. Africa Genomic Biomarkers Market Overview

34.2. Africa Genomic Biomarkers Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Genomic Biomarkers Market Regulatory and Investment Landscape

36. Genomic Biomarkers Market Competitive Landscape And Company Profiles

36.1. Genomic Biomarkers Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Genomic Biomarkers Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Genomic Biomarkers Market Company Profiles

36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Almac Group Overview, Products and Services, Strategy and Financial Analysis

37. Genomic Biomarkers Market Other Major And Innovative Companies

Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4

38. Global Genomic Biomarkers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Genomic Biomarkers Market

40. Genomic Biomarkers Market High Potential Countries, Segments and Strategies

40.1 Genomic Biomarkers Market In 2030 - Countries Offering Most New Opportunities

40.2 Genomic Biomarkers Market In 2030 - Segments Offering Most New Opportunities

40.3 Genomic Biomarkers Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Genomic Biomarkers Market, Overview Of Key Products - Product Examples

Table 2: Global Genomic Biomarkers Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Genomic Biomarkers Market, Supply Chain Analysis

Table 4: Global Genomic Biomarkers Market, Major Raw Material Providers

Table 5: Global Genomic Biomarkers Market, Major Resource Providers

Table 6: Global Genomic Biomarkers Market, Major Manufacturers (Suppliers)

Table 7: Global Genomic Biomarkers Market, Major Distributors And Channel Partners

Table 8: Global Genomic Biomarkers Market, Key Technologies & Future Trends

Table 9: Global Genomic Biomarkers Market, Major Trends

Table 10: Global Genomic Biomarkers Market, Major End Users

Table 11: Global Genomic Biomarkers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Genomic Biomarkers Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Genomic Biomarkers Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Genomic Biomarkers Market - TAM, US$ Billion, 2025

Table 15: Global Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Genomic Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Genomic Biomarkers Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Genomic Biomarkers Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Genomic Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Genomic Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Genomic Biomarkers Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Genomic Biomarkers Market - Company Scoring Matrix

Table 97: Thermo Fisher Scientific Inc. Financial Performance

Table 98: Roche Diagnostics International Ltd. Financial Performance

Table 99: Illumina Inc. Financial Performance

Table 100: PerkinElmer Inc. Financial Performance

Table 101: Almac Group Financial Performance

Table 102: Global Genomic Biomarkers Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Genomic Biomarkers Market, Competitive Dashboard

Table 104: Global Genomic Biomarkers Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Genomic Biomarkers Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 106: Global, Genomic Biomarkers Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

Table 107: Global, Genomic Biomarkers Market Size Gain ($ Billion), Segmentation By Validation, 2025 – 2030

List Of Figures

Figure 1: Global Genomic Biomarkers Market, Overview Of Key Products - Product Examples

Figure 2: Global Genomic Biomarkers Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Genomic Biomarkers Market, Supply Chain Analysis

Figure 4: Global Genomic Biomarkers Market, Major Raw Material Providers

Figure 5: Global Genomic Biomarkers Market, Major Resource Providers

Figure 6: Global Genomic Biomarkers Market, Major Manufacturers (Suppliers)

Figure 7: Global Genomic Biomarkers Market, Major Distributors And Channel Partners

Figure 8: Global Genomic Biomarkers Market, Key Technologies & Future Trends

Figure 9: Global Genomic Biomarkers Market, Major Trends

Figure 10: Global Genomic Biomarkers Market, Major End Users

Figure 11: Global Genomic Biomarkers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Genomic Biomarkers Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Genomic Biomarkers Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Genomic Biomarkers Market - TAM, US$ Billion, 2025

Figure 15: Global Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Genomic Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Genomic Biomarkers Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Genomic Biomarkers Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Genomic Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Genomic Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Genomic Biomarkers Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Genomic Biomarkers Market - Company Scoring Matrix

Figure 97: Thermo Fisher Scientific Inc. Financial Performance

Figure 98: Roche Diagnostics International Ltd. Financial Performance

Figure 99: Illumina Inc. Financial Performance

Figure 100: PerkinElmer Inc. Financial Performance

Figure 101: Almac Group Financial Performance

Figure 102: Global Genomic Biomarkers Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Genomic Biomarkers Market, Competitive Dashboard

Figure 104: Global Genomic Biomarkers Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Genomic Biomarkers Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 106: Global, Genomic Biomarkers Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

Figure 107: Global, Genomic Biomarkers Market Size Gain ($ Billion), Segmentation By Validation, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Type 1 Diabetes Market Report 2026 - Global Outlook – By Product Type (Rapid Acting Insulin Analogs, Long-Acting Insulin Analogs, Premix Insulin Analogs, Others Product Types), By Device (Insulin Pump, Insulin Pen, Blood...

Border Security Market Report 2026 - Global Outlook – By Component (Laser, Radar, Camera, Perimeter intrusion, Other Components), By System (Cargo Scanner, Elemental Isotope Detector, Ground Sensor, Radar System, Night-V...

Serverless Architecture Market Report 2026 - Global Outlook – By Service (Automation And Integration, Application Programming Interfaces (APIs) Management, Monitoring, Security, Support And Maintenance, Training And Cons...

Rubber Gloves Market Report 2026 - Global Outlook – By Usage Type (Powdered, Powder Free), By Material (Natural Rubber Or Latex, Nitrile, Neoprene, Other Materials), By Product (Disposable, Durable), By Distribution Chan...

Heart Attack Diagnostic Market Report 2026 - Global Outlook – By Test Type (Electrocardiogram (ECG Or EKG), Blood Tests, Echocardiogram, Coronary Catheterization (Angiogram)), By Procedure (Invasive Procedure, Non-Invasi...

Silicon On Insulator (SOI) Market Report 2026 - Global Outlook – By Type ( Fully Depleted Silicon On Insulator (Fd-SoI), Partially Depleted Silicon On Insulator (Pd- SoI), Power- SoI, Other Types ), By Wafer Size ( Less ...

Frequently Asked Questions

How big is the Genomic Biomarkers Market?

The Genomic Biomarkers market was valued at $8.72 billion in 2025, increased to $10.24 billion in 2026, and is projected to reach $19.33 billion by 2030.

What is the Genomic Biomarkers market growth?

The global Genomic Biomarkers market is expected to grow at a CAGR of 17.2% from 2026 to 2035 to reach $19.33 billion by 2035.

Who are the key players in Genomic Biomarkers market?

Some Key Players in the Genomic Biomarkers market Include, Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4 .

What is the anticipated growth trend for the Genomic Biomarkers market?

Major trend in this market includes: Advancements In Genomic Biomarkers To Enhance Precision Medicine In Lung Cancer. For further insights on this market. request a sample here

Which region has the most growth potential in the Genomic Biomarkers market?

North America was the largest region in the genomic biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.